HURWITZ EDWARD
Insider CIK 1211840 · SNSS Director · MGNX Director · AGTC Director · AEGR 10% owner · CARA Director, 10% owner · DYN Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2026-06-05 | 2026-06-09 | 35,152 | — | $0 | 35,152 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2026-05-19 | 2026-05-20 | 3,750 | — | $0 | 3,750 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2026-05-19 | 2026-05-20 | 22,000 | — | $0 | 22,000 | SEC↗ |
| MGNX MACROGENICS INC | M Exercise deriv | 2026-05-18 | 2026-05-20 | 3,750 | — | $0 | 0 | SEC↗ |
| MGNX MACROGENICS INC | M Exercise | 2026-05-18 | 2026-05-20 | 3,750 | — | $0 | 47,824 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2025-05-30 | 2025-06-03 | 35,000 | — | $0 | 35,000 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2025-05-21 | 2025-05-22 | 3,750 | — | $0 | 3,750 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2025-05-21 | 2025-05-22 | 22,000 | — | $0 | 22,000 | SEC↗ |
| MGNX MACROGENICS INC | M Exercise deriv | 2025-05-20 | 2025-05-22 | 6,500 | — | $0 | 0 | SEC↗ |
| MGNX MACROGENICS INC | M Exercise | 2025-05-20 | 2025-05-22 | 6,500 | — | $0 | 44,074 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2024-05-22 | 2024-05-24 | 25,133 | — | $0 | 25,133 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2024-05-21 | 2024-05-23 | 16,500 | — | $0 | 16,500 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2024-05-21 | 2024-05-23 | 6,500 | — | $0 | 6,500 | SEC↗ |
| MGNX MACROGENICS INC | M Exercise deriv | 2024-05-20 | 2024-05-22 | 4,500 | — | $0 | 0 | SEC↗ |
| MGNX MACROGENICS INC | M Exercise | 2024-05-20 | 2024-05-22 | 4,500 | — | $0 | 37,574 | SEC↗ |
| MGNX MACROGENICS INC | P Buy | 2023-08-30 | 2023-09-01 | 15,000 | $4.91 | $73.7K | 33,074 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2023-05-31 | 2023-06-02 | 19,000 | — | $0 | 19,000 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2023-05-31 | 2023-06-02 | 4,500 | — | $0 | 4,500 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2023-05-24 | 2023-05-25 | 24,900 | — | $0 | 24,900 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 4,688 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 9,375 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 14,000 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 12,000 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 10,000 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 10,000 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 10,000 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 8,000 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 6,200 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | U Tender | 2022-11-30 | 2022-12-01 | 1,800 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | U Tender | 2022-11-30 | 2022-12-01 | 25,672 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2022-06-03 | 2022-06-06 | 19,596 | — | $0 | 19,596 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2022-05-19 | 2022-05-23 | 18,000 | — | $0 | 18,000 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2021-11-30 | 2021-12-02 | 14,000 | — | $0 | 14,000 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2021-05-26 | 2021-05-27 | 19,596 | — | $0 | 19,596 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2021-05-13 | 2021-05-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2020-12-16 | 2020-12-18 | 12,000 | — | $0 | 12,000 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 275,932 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 1,326,313 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 70,492 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 26,176 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 743,076 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 13,980,992 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion | 2020-09-21 | 2020-09-23 | 4,614,943 | — | $0 | 4,614,943 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion | 2020-09-21 | 2020-09-23 | 245,279 | — | $0 | 245,279 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion | 2020-09-21 | 2020-09-23 | 91,081 | — | $0 | 91,081 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | P Buy deriv | 2020-08-07 | 2020-09-23 | 1,326,313 | $2.81 | $3.73M | 1,326,313 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | P Buy deriv | 2020-08-07 | 2020-09-23 | 70,492 | $2.81 | $198.1K | 70,492 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | P Buy deriv | 2020-08-07 | 2020-09-23 | 26,176 | $2.81 | $73.6K | 26,176 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | P Buy deriv | 2020-07-31 | 2020-09-23 | 4,893,347 | $1.00 | $4.89M | 13,980,992 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | P Buy deriv | 2020-07-31 | 2020-09-23 | 260,077 | $1.00 | $260.1K | 743,076 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | P Buy deriv | 2020-07-31 | 2020-09-23 | 96,576 | $1.00 | $96.6K | 275,932 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2020-05-14 | 2020-05-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2019-12-04 | 2019-12-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2019-05-16 | 2019-05-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2018-11-15 | 2018-11-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2018-07-25 | 2018-07-27 | 8,000 | — | $0 | 8,000 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2018-07-25 | 2018-07-30 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | J Other | 2018-05-24 | 2018-05-29 | 25,672 | — | $0 | 27,472 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2018-05-17 | 2018-05-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2017-05-18 | 2017-05-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2017-02-28 | 2017-03-02 | 8,000 | — | $0 | 8,000 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2016-05-18 | 2016-05-20 | 8,500 | — | $0 | 8,500 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2015-11-19 | 2015-12-04 | 6,200 | — | $0 | 6,200 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2015-05-20 | 2015-05-21 | 8,500 | — | $0 | 8,500 | SEC↗ |
| MGNX MACROGENICS INC | J Other | 2015-05-11 | 2015-05-13 | 18,074 | — | $0 | 18,074 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2014-12-19 | 2014-12-23 | 4,688 | — | $0 | 4,688 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | J Other | 2014-11-17 | 2014-11-19 | 1,800 | — | $0 | 1,800 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2014-06-05 | 2014-06-09 | 6,924 | — | $0 | 6,924 | SEC↗ |
| MGNX MACROGENICS INC | S Sale | 2014-02-18 | 2014-02-18 | 308,513 | $36.50 | $11.26M | 1,704,996 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion deriv | 2014-02-05 | 2014-02-05 | 89,227 | — | $0 | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion deriv | 2014-02-05 | 2014-02-05 | 1,328,604 | — | $0 | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion deriv | 2014-02-05 | 2014-02-05 | 32,742 | — | $0 | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion deriv | 2014-02-05 | 2014-02-05 | 158,741 | — | $0 | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion deriv | 2014-02-05 | 2014-02-05 | 2,363,654 | — | $0 | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion deriv | 2014-02-05 | 2014-02-05 | 58,250 | — | $0 | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | P Buy | 2014-02-05 | 2014-02-05 | 6,940 | $11.00 | $76.3K | 117,760 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion | 2014-02-05 | 2014-02-05 | 1,118,675 | — | $0 | 1,118,675 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion | 2014-02-05 | 2014-02-05 | 531,442 | — | $0 | 1,650,117 | SEC↗ |
| CARA Cara Therapeutics, Inc. | P Buy | 2014-02-05 | 2014-02-05 | 103,330 | $11.00 | $1.14M | 1,753,447 | SEC↗ |
| CARA Cara Therapeutics, Inc. | P Buy | 2014-02-05 | 2014-02-05 | 2,547 | $11.00 | $28.0K | 43,212 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion | 2014-02-05 | 2014-02-05 | 13,097 | — | $0 | 40,665 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion | 2014-02-05 | 2014-02-05 | 27,568 | — | $0 | 27,568 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion | 2014-02-05 | 2014-02-05 | 35,691 | — | $0 | 110,820 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion | 2014-02-05 | 2014-02-05 | 75,129 | — | $0 | 75,129 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award deriv | 2014-01-30 | 2014-01-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MGNX MACROGENICS INC | X Exercise deriv | 2013-10-16 | 2013-10-18 | 287,533 | — | $0 | 0 | SEC↗ |
| MGNX MACROGENICS INC | C Conversion deriv | 2013-10-16 | 2013-10-18 | 3,833,767 | — | $0 | 0 | SEC↗ |
| MGNX MACROGENICS INC | C Conversion deriv | 2013-10-16 | 2013-10-18 | 12,328,024 | — | $0 | 0 | SEC↗ |
| MGNX MACROGENICS INC | C Conversion deriv | 2013-10-16 | 2013-10-18 | 18,728,346 | — | $0 | 0 | SEC↗ |
| MGNX MACROGENICS INC | C Conversion | 2013-10-16 | 2013-10-18 | 1,137,332 | — | $0 | 1,137,332 | SEC↗ |
| MGNX MACROGENICS INC | C Conversion | 2013-10-16 | 2013-10-18 | 204,206 | — | $0 | 1,998,195 | SEC↗ |
| MGNX MACROGENICS INC | X Exercise | 2013-10-16 | 2013-10-18 | 15,314 | — | $0 | 2,013,509 | SEC↗ |
| MGNX MACROGENICS INC | C Conversion | 2013-10-16 | 2013-10-18 | 656,657 | — | $0 | 1,793,989 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2013-10-09 | 2013-10-11 | 13,849 | — | $0 | 13,849 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2013-06-28 | 2013-07-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2012-10-16 | 2012-10-17 | 3,160 | $18.67 | $59.0K | 56,190 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2012-10-16 | 2012-10-17 | 128,229 | $18.67 | $2.39M | 2,280,197 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2012-10-16 | 2012-10-17 | 8,611 | $18.67 | $160.8K | 153,131 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2012-10-15 | 2012-10-17 | 1,371 | $17.54 | $24.0K | 59,350 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2012-10-15 | 2012-10-17 | 55,626 | $17.54 | $975.7K | 2,408,426 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2012-10-15 | 2012-10-17 | 3,736 | $17.54 | $65.5K | 161,742 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2012-06-29 | 2012-07-02 | 25,000 | — | $0 | 25,000 | SEC↗ |